Mukadam

Dr. Lalpathlabs thrust towards 3997

Long
NSE:LALPATHLAB   DR LAL PATHLABS LTD
Targets 3478 and 3997 as the 3rd Wave arrives

Good Fundamentals:
High Management Efficiency with a high ROE of 22.80%
Company has a low Debt to Equity ratio ( avg ) at -0.79 times
With a growth in Net Profit of 161.04%, the company declared Very Positive results in Mar 21
The company has declared positive results for the last 2 consecutive quartersPBT LESS OI(Q) At Rs 97.30 cr has Grown at 191.32 %PAT(Q) At Rs 83. 40 cr has Grown at 156.6 %ROCE(HY) Highest at 32.96 %
High Institutional Holdings at 33.53%
These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Trade closed: target reached: Idea closed at 4000 after achieving 2nd target with profit of 18%